[go: up one dir, main page]

MX2018005520A - Metodos para preparacion de acido obeticolico y derivados de los mismos. - Google Patents

Metodos para preparacion de acido obeticolico y derivados de los mismos.

Info

Publication number
MX2018005520A
MX2018005520A MX2018005520A MX2018005520A MX2018005520A MX 2018005520 A MX2018005520 A MX 2018005520A MX 2018005520 A MX2018005520 A MX 2018005520A MX 2018005520 A MX2018005520 A MX 2018005520A MX 2018005520 A MX2018005520 A MX 2018005520A
Authority
MX
Mexico
Prior art keywords
derivatives
preparation
methods
obeticholic acid
klca
Prior art date
Application number
MX2018005520A
Other languages
English (en)
Inventor
M Galvin Gabrial
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of MX2018005520A publication Critical patent/MX2018005520A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • C07J41/0061—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives one of the carbon atoms being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente solicitud se refiere a un método para preparar un derivado de ácido biliar, o una sal, solvato o conjugado de aminoácidos farmacéuticamente aceptable del mismo, que comprende la alquilación directa en la posición C-6 de KLCA.
MX2018005520A 2015-11-06 2016-10-28 Metodos para preparacion de acido obeticolico y derivados de los mismos. MX2018005520A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562252077P 2015-11-06 2015-11-06
PCT/US2016/059440 WO2017079062A1 (en) 2015-11-06 2016-10-28 Methods for the preparation of obeticholic acid and derivatives thereof

Publications (1)

Publication Number Publication Date
MX2018005520A true MX2018005520A (es) 2018-08-01

Family

ID=58662647

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018005520A MX2018005520A (es) 2015-11-06 2016-10-28 Metodos para preparacion de acido obeticolico y derivados de los mismos.

Country Status (14)

Country Link
US (1) US10604545B2 (es)
EP (1) EP3370728A4 (es)
JP (1) JP6749406B2 (es)
KR (1) KR20180067699A (es)
CN (1) CN108348533A (es)
AR (1) AR106587A1 (es)
AU (1) AU2016350690C1 (es)
BR (1) BR112018008936A2 (es)
CA (1) CA3004275A1 (es)
HK (1) HK1254055A1 (es)
IL (1) IL258922A (es)
MX (1) MX2018005520A (es)
TW (1) TW201720839A (es)
WO (1) WO2017079062A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019020067A1 (zh) * 2017-07-26 2019-01-31 正大天晴药业集团股份有限公司 甾体类衍生物fxr激动剂的制备方法
CN107383139A (zh) * 2017-08-09 2017-11-24 杭州和泽医药科技有限公司 一种3α‑羟基‑7‑氧代‑5β‑胆烷酸新衍生物制备奥贝胆酸的方法
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
WO2021029656A1 (ko) * 2019-08-14 2021-02-18 주식회사 바이오톡스텍 하이드로퀴논 유도체, 및 오베티콜릭산을 포함하는 비알콜성 지방간염의 예방 또는 치료용 약학조성물
CN114945560B (zh) 2019-10-07 2024-08-13 卡尔优普公司 Gpr119激动剂
CN115667277A (zh) 2020-02-28 2023-01-31 卡尔优普公司 Gpr40激动剂
UY39222A (es) 2020-05-19 2021-11-30 Kallyope Inc Activadores de la ampk
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CA3190433A1 (en) * 2020-08-21 2022-02-24 Sandhill One, Llc Methods of making cholic acid derivatives and starting materials therefor
WO2023081658A2 (en) 2021-11-02 2023-05-11 Sandhill One, Llc High purity non-animal derived tudca
WO2023081657A2 (en) 2021-11-02 2023-05-11 Sandhill One, Llc High purity non-animal derived udca
CA3235454A1 (en) 2021-11-02 2023-05-11 Sandhill One, Llc Stereoselective steroidal reductions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06279488A (ja) * 1993-03-29 1994-10-04 Kuraray Co Ltd 新規なステロイド誘導体および骨粗鬆症治療剤
US7138390B2 (en) * 2001-03-12 2006-11-21 Intercept Pharmaceuticals Steroids as agonists for FXR
ITMI20050912A1 (it) 2005-05-19 2006-11-20 Erregierre Spa Processo di preparazione di acidi 3-a-ya(b)-diidrossi-6-a(b)-alchil-5b-colanici
US8338628B2 (en) * 2007-08-28 2012-12-25 City Of Hope Method of synthesizing alkylated bile acid derivatives
US10149921B2 (en) 2012-02-07 2018-12-11 The Regents Of The University Of California Implants having tantalum coated nanostructures
SG11201408501UA (en) * 2012-06-19 2015-01-29 Intercept Pharmaceuticals Inc Preparation, uses and solid forms of obeticholic acid
AU2013334122B2 (en) * 2012-10-26 2017-11-02 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives
CN104876995B (zh) * 2014-02-27 2016-09-07 人福医药集团股份公司 鹅去氧胆酸衍生物的制备方法
CN104558086B (zh) * 2014-12-25 2016-10-05 康美（北京）药物研究院有限公司 一种5β-3α,7α-二羟基-6α-乙基-胆烷酸的制备方法

Also Published As

Publication number Publication date
US20190062367A1 (en) 2019-02-28
AU2016350690C1 (en) 2020-04-23
IL258922A (en) 2018-06-28
HK1254055A1 (zh) 2019-07-12
AU2016350690A1 (en) 2018-05-10
WO2017079062A1 (en) 2017-05-11
AR106587A1 (es) 2018-01-31
CA3004275A1 (en) 2017-05-11
EP3370728A4 (en) 2019-07-10
EP3370728A1 (en) 2018-09-12
TW201720839A (zh) 2017-06-16
CN108348533A (zh) 2018-07-31
BR112018008936A2 (pt) 2018-11-27
JP2018532800A (ja) 2018-11-08
KR20180067699A (ko) 2018-06-20
US10604545B2 (en) 2020-03-31
JP6749406B2 (ja) 2020-09-02
AU2016350690B2 (en) 2019-12-12

Similar Documents

Publication Publication Date Title
MX2018005520A (es) Metodos para preparacion de acido obeticolico y derivados de los mismos.
MX2018001491A (es) Metodos para la preparacion de acidos biliares y derivados de los mismos.
ZA201808286B (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
MA43066A (fr) Procédés de préparation d'acides biliaires et de leurs dérivés
HRP20181806T1 (hr) Novi aminokiselinski derivati, postupak za njihovu pripravu te farmaceutski pripravci koji ih sadrže
IL254124A0 (en) New 3-indole-transformed histories, medicinal preparations and methods of use
PH12018500777A1 (en) Farnesoid x receptor modulators
SG10201804817TA (en) Delayed release compositions of linaclotide
BR112015022041A2 (pt) derivados substituídos de 3-fenilpropilamina para o tratamento de doenças e distúrbios oftálmicas
EP3176163A4 (en) Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient
SA520411635B1 (ar) A2a مشتق حلقي مدمج كمثبط مستقبل
HUP1500618A2 (en) Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical composition containing them
MX385672B (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida.
MX374550B (es) Métodos para preparación de ácido obeticólico y derivados de los mismos.
PL3398946T3 (pl) Sól pochodnej morfolinowej i jej postać krystaliczna, jak również sposób jej wytwarzania, kompozycja farmaceutyczna i jej zastosowanie
EP3378479A4 (en) Method for preparing pharmaceutical composition comprising quinoline derivative or salt thereof
HUE059610T2 (hu) Gyógyszerészeti készítmény, amely indolszármazékokat tartalmaz, valamint eljárás annak elõállítására és felhasználására
IL277066A (en) History of LNA-dicarboxylic acid and process for their preparation
IL262490A (en) Lomacaptor complexes and their salts and derivatives, a process for their preparation and pharmaceutical preparations containing them
IL262489A (en) Complexes of ivacaptor and its salts and their history, a process for their preparation and pharmaceutical preparations containing them
HK40005618A (en) Complexes of ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HK40005617A (en) Complexes of lumacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them
ZA201803722B (en) Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
MX2019009230A (es) Composicion que comprende capecitabina de liberacion inmediata y liberacion prolongada.
MX2012014969A (es) Composiciones farmaceuticas estables de amlodipina con telmisartan.